Search Results

There are 19032 results for: content related to: Cytokines in pancreatic carcinoma

  1. You have free access to this content
    Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell–specific interleukin-1 receptor antagonist

    Arthritis & Rheumatism

    Volume 62, Issue 2, February 2010, Pages: 452–462, Céline Lamacchia, Gaby Palmer, Christian A. Seemayer, Dominique Talabot-Ayer and Cem Gabay

    Version of Record online : 7 JAN 2010, DOI: 10.1002/art.27235

  2. You have free access to this content
    Production of IL-1 receptor antagonist by hepatocytes is regulated as an acute-phase protein in vivo

    European Journal of Immunology

    Volume 31, Issue 2, February 2001, Pages: 490–499, Cem Gabay, Jason Gigley, Jean Sipe, William P. Arend and Giamila Fantuzzi

    Version of Record online : 31 JAN 2001, DOI: 10.1002/1521-4141(200102)31:2<490::AID-IMMU490>3.0.CO;2-H

  3. Release of WBC-derived IL-1 receptor antagonist into supernatants of RBCs: influence of storage time and filtration

    Transfusion

    Volume 41, Issue 1, January 2001, Pages: 67–73, Ivana Büttnerova, Hans Bäumler, Florian Kern, Hartmut Radtke, Hans-Dieter Volk, Holger Kiesewetter and Wolf-Dietrich Döcke

    Version of Record online : 21 APR 2002, DOI: 10.1046/j.1537-2995.2001.41010067.x

  4. You have free access to this content
    Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1β–stimulated rat synovial fibroblasts via a peroxisome proliferator–activated receptor β/δ–dependent mechanism

    Arthritis & Rheumatism

    Volume 52, Issue 3, March 2005, Pages: 759–769, David Moulin, Arnaud Bianchi, Sandrine Boyault, Sylvie Sebillaud, Meriem Koufany, Mathias Francois, Patrick Netter, Jean-Yves Jouzeau and Bernard Terlain

    Version of Record online : 4 MAR 2005, DOI: 10.1002/art.20868

  5. You have free access to this content
    IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?

    FEBS Letters

    Volume 580, Issue 27, November 27, 2006, Pages: 6289–6294, Stephane Perrier, Froogh Darakhshan and Eric Hajduch

    Version of Record online : 3 NOV 2006, DOI: 10.1016/j.febslet.2006.10.061

  6. A preliminary in vitro study into the use of IL-1Ra gene therapy for the inhibition of intervertebral disc degeneration

    International Journal of Experimental Pathology

    Volume 87, Issue 1, February 2006, Pages: 17–28, Christine L. Le Maitre, Anthony J. Freemont and Judith A. Hoyland

    Version of Record online : 23 JAN 2006, DOI: 10.1111/j.0959-9673.2006.00449.x

  7. You have free access to this content
    IL-1ra and IL-1 production in human oral mucosal epithelial cells in culture: differential modulation by TGF-β1 and IL-4

    Clinical & Experimental Immunology

    Volume 127, Issue 1, January 2002, Pages: 53–59, S. Perrier, B. Kherratia, C. Deschaumes, S. Ughetto, J. -L. Kemeny, M. Baudet-Pommel and B. Sauvezie

    Version of Record online : 7 FEB 2002, DOI: 10.1046/j.1365-2249.2002.01685.x

  8. You have free access to this content
    Rapid brain penetration of interleukin-1 receptor antagonist in rat cerebral ischaemia: pharmacokinetics, distribution, protection

    British Journal of Pharmacology

    Volume 160, Issue 1, May 2010, Pages: 153–159, AD Greenhalgh, J Galea, A Dénes, PJ Tyrrell and NJ Rothwell

    Version of Record online : 24 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00684.x

  9. You have free access to this content
    Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: A possible role in the resolution of arthritis

    Arthritis & Rheumatism

    Volume 44, Issue 2, February 2001, Pages: 451–462, Cem Gabay, Liliana Marinova-Mutafchieva, Richard O. Williams, Jason P. Gigley, Debra M. Butler, Marc Feldmann and William P. Arend

    Version of Record online : 28 FEB 2001, DOI: 10.1002/1529-0131(200102)44:2<451::AID-ANR64>3.0.CO;2-H

  10. Treatment with granulocyte colony-stimulating factor increases interleukin-1 receptor antagonist levels during engraftment following allogeneic stem-cell transplantation

    European Journal of Clinical Investigation

    Volume 34, Issue 11, November 2004, Pages: 759–765, M. Schwabe, A.-M. Hartert, H. Bertz and J. Finke

    Version of Record online : 3 NOV 2004, DOI: 10.1111/j.1365-2362.2004.01421.x

  11. You have free access to this content
    Role of endogenous interleukin-1 receptor antagonist in regulating fever induced by localised inflammation in the rat

    The Journal of Physiology

    Volume 531, Issue 1, February 2001, Pages: 171–180, T. Cartmell, G. N. Luheshi, S. J. Hopkins, N. J. Rothwell and S. Poole

    Version of Record online : 5 AUG 2004, DOI: 10.1111/j.1469-7793.2001.0171j.x

  12. Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia

    Glia

    Volume 53, Issue 5, 1 April 2006, Pages: 551–556, Emmanuel Pinteaux, Nancy J. Rothwell and Herve Boutin

    Version of Record online : 22 DEC 2005, DOI: 10.1002/glia.20308

  13. You have free access to this content
    Development and characterization of a fusion protein between thermally responsive elastin-like polypeptide and interleukin-1 receptor antagonist: Sustained release of a local antiinflammatory therapeutic

    Arthritis & Rheumatism

    Volume 56, Issue 11, November 2007, Pages: 3650–3661, Mohammed F. Shamji, Helawe Betre, Virginia B. Kraus, Jun Chen, Ashutosh Chilkoti, Rajeswari Pichika, Koichi Masuda and Lori A. Setton

    Version of Record online : 29 OCT 2007, DOI: 10.1002/art.22952

  14. Interleukin-1 receptor antagonist: A new therapy for type 2 diabetes mellitus

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 5, May 2012, Pages: 1647–1658, Muhammad Sajid Hamid Akash, Qi Shen, Kanwal Rehman and Shuqing Chen

    Version of Record online : 23 JAN 2012, DOI: 10.1002/jps.23057

  15. Electrotransfer of human IL-1Ra into skeletal muscles reduces the incidence of murine collagen-induced arthritis

    The Journal of Gene Medicine

    Volume 6, Issue 10, October 2004, Pages: 1125–1133, Jae-Gyun Jeong, Jong-Mook Kim, Seong-Hyun Ho, Woong Hahn, Seung Shin Yu and Sunyoung Kim

    Version of Record online : 28 SEP 2004, DOI: 10.1002/jgm.599

  16. You have free access to this content
    Anti-type II collagen antibody accelerates arthritis via CXCR2-expressing cells in IL-1 receptor antagonist-deficient mice

    European Journal of Immunology

    Volume 37, Issue 10, October 2007, Pages: 2753–2763, Takashi Kagari, Daisuke Tanaka, Hiromi Doi, Yoichiro Iwakura and Takaichi Shimozato

    Version of Record online : 7 SEP 2007, DOI: 10.1002/eji.200737313

  17. You have free access to this content
    Biodistribution, pharmacokinetics and metabolism of interleukin-1 receptor antagonist (IL-1RA) using [18F]-IL1RA and PET imaging in rats

    British Journal of Pharmacology

    Volume 162, Issue 3, February 2011, Pages: 659–672, C Cawthorne, C Prenant, A Smigova, P Julyan, R Maroy, K Herholz, N Rothwell and H Boutin

    Version of Record online : 12 JAN 2011, DOI: 10.1111/j.1476-5381.2010.01068.x

  18. Aberrant interleukin-1 signalling does not increase susceptibility of mice to NOD2-dependent uveitis

    Clinical & Experimental Ophthalmology

    Volume 43, Issue 4, May/June 2015, Pages: 349–357, Ellen J Lee, Jordan J Allensworth, Jenna S Clowers and Holly L Rosenzweig

    Version of Record online : 30 OCT 2014, DOI: 10.1111/ceo.12438

  19. You have free access to this content
    Brain sites of action of endogenous interleukin-1 in the febrile response to localized inflammation in the rat

    The Journal of Physiology

    Volume 518, Issue 2, July 1999, Pages: 585–594, T. Cartmell, G. N. Luheshi and N. J. Rothwell

    Version of Record online : 7 SEP 2004, DOI: 10.1111/j.1469-7793.1999.0585p.x

  20. IL-1 receptor antagonist levels are associated with glucose tolerance in polycystic ovary syndrome

    Clinical Endocrinology

    Kari Luotola, Terhi T. Piltonen, Johanna Puurunen and Juha S. Tapanainen

    Version of Record online : 26 APR 2016, DOI: 10.1111/cen.13077